Uterine Cancer

1. Front Matter

   Pages i-xii

   PDF

2. The Essential Epidemiology of Cancer of the Endometrium: An Update

   • Malcolm C. Pike, Karine Chung, Sara Olson, Celeste L. Pearce, Anna H. Wu

   Pages 1-11

3. Endometrial Cancer: Screening, Diagnosis, and Surgical Staging

   • Annekathryn Goodman

   Pages 13-23

4. Imaging in the Diagnosis and Treatment of Endometrial Cancer

   • Jessica J. Kraeft, Susanna I. Lee

   Pages 25-41

5. Uterine Cancer: Pathology

   • Robert A. Soslow, Esther Oliva

   Pages 47-81

6. Molecular Pathology and Cytogenetics of Endometrial Carcinoma, Carcinosarcoma, and Uterine Sarcomas

   • Jose Palacios, Paola Dal Cin

   Pages 85-103

7. Prognostic Factors in Uterine Cancer

   • Patricia M. Baker, Esther Oliva

   Pages 107-146

8. Primary Hormonal Therapy of Endometrial Cancer

   • Linda R. Duska

   Pages 151-169

9. Early-Stage Endometrial Cancer: Surgery

   • Yukio Sonoda, George Monemvasitis

   Pages 171-181

10. Early-Stage Endometrial Cancer: Radiation—Less May Be More

    • Onyinye Balogun, Stella Lymberis, Peter B. Schiff

    Pages 183-199

11. Therapeutic Modalities in Early-Stage Uterine Papillary Serous Carcinomas, Carcinosarcomas, Clear-Cell and Mixed Histology Carcinomas: Treatment of Choice Is Combined Chemotherapy and Radiation

    • Laura M. Divine, Matthew A. Powell

    Pages 201-221

12. Treatment of Advanced and Recurrent Carcinoma: Chemotherapy

    • Fernanda Musa

    Pages 223-233

13. Treatment for Advanced and Recurrent Carcinoma: Combined Modalities

    • Marcela G. del Carmen, Neil S. Horowitz

    Pages 235-246

14. Management of Uterine Sarcomas

    • Leslie R. Boyd

    Pages 247-257

15. Future Directions and New Targets in Endometrial Cancer

    • Jonathan D. Black, Dana M. Roque, Leslie I. Gold, Alessandro D. Santin

    Pages 259-271

16. Erratum to: Molecular Pathology and Cytogenetics of Endometrial Carcinoma, Carcinosarcoma, and Uterine Sarcomas

    • Jose Palacios, Paola Dal Cin

    Pages 105-105

17. Erratum to: Prognostic Factors in Uterine Cancer

    • Patricia M. Baker, Esther Oliva

    Pages 147-149

18. Erratum to: Imaging in the Diagnosis and Treatment of Endometrial Cancer

    • Jessica J. Kraeft, Susanna I. Lee

    Pages 43-45

19. Erratum to: Uterine Cancer: Pathology

    • Robert A. Soslow, Esther Oliva

    Pages 83-84

20. Back Matter

    Pages 273-278

    PDF

There are more than 63,000 new cases of uterine and endometrial cancer each year in the United States, up from approximately 41,000 when the first edition of Uterine Cancer was published in 2009. A book focusing on these cancers was timely, with emergent sophistication in diagnosis increasingly impacting clinical decision-making. However, five years later, the need for an updated book on this topic is even stronger as oncologists recognize opportunities to impact the outcome on women that are increasingly diagnosed with these malignancies. Uterine Cancer: Screening, Diagnosis, and Treatment, Second Edition, ​part of the Current Clinical Oncology series, enhances the awareness on this somewhat neglected area of therapeutics, helping to integrate targeted therapies into the management of women with uterine cancer. Written by experts in the field in a highly practical and comprehensive manner, it is a must-have for all gynecological residents and fellows, as well as gynecological oncologists, medical oncologists, radiation oncologists, and family practice doctors who wish to provide their patients with the best possible care.

• Cancer screening
• Uterine Cancer
• gynecology
• oncology
• radiology

• NYU Langone Medical Center, New York, USA

  Franco Muggia

• Division of Gynecologic Oncology, Yale University, Yale School of Medicine, New Haven, USA

  Alessandro D. Santin

• Department of Pathology, Massachusetts General Hospital, Boston, USA

  Esther Oliva

• Harvard Medical School, Boston, USA

  Esther Oliva

Dr. Franco Muggia is a Professor in the Department of Medicine at the Perlmutter Cancer Center at NYU Langone. His medical expertise include gynecologic cancers, breast cancer, and gynecologic oncology. Dr. Alessandro Santin is a Professor of Obstetrics, Gynecology, and Reproductive Sciences at Yale School of Medicine. He is also the Clinical Research Program Leader in the Gynecologic Oncology Program at Yale Cancer Center. Dr. Esther Oliva is a Pathologist at Massachusetts General Hospital and a Professor of Pathology at Harvard Medical School.

Policies and ethics